Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Alimentary pharmacology and therapeutics

Results: 26-50/1697

Authors: Wong, BCY Wang, WP So, WHL Shin, VY Wong, WM Fung, FMY Liu, ESL Hiu, WM Lam, SK Cho, CH
Citation: Bcy. Wong et al., Epidermal growth factor and its receptor in chronic active gastritis and gastroduodenal ulcer before and after Helicobacter pylori eradication, ALIM PHARM, 15(9), 2001, pp. 1459-1465

Authors: Leung, WK Yu, J To, KF Go, MYY Ma, PK Chan, FKL Sung, JJY
Citation: Wk. Leung et al., Apoptosis and proliferation in Helicobacter pylori-associated gastric intestinal metaplasia, ALIM PHARM, 15(9), 2001, pp. 1467-1472

Authors: Parsons, HK Carter, MJ Sanders, DS Winstanley, T Lobo, AJ
Citation: Hk. Parsons et al., Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status, ALIM PHARM, 15(9), 2001, pp. 1473-1478

Authors: Hokari, K Sugiyama, T Kato, M Saito, M Miyagishima, T Kudo, M Nishikawa, K Ishizuka, J Komatsu, Y Mizushima, T Kagaya, H Hige, S Takeda, H Asaka, M
Citation: K. Hokari et al., Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism, ALIM PHARM, 15(9), 2001, pp. 1479-1484

Authors: Ishihara, S Okuyama, T Ishimura, N Ono, M Hashimoto, T Kazumori, H Kaji, T Sato, H Fujishiro, H Adachi, K Fukuda, R Kinoshita, Y
Citation: S. Ishihara et al., Intragastric distribution of Helicobacter pylori during short-term omeprazole therapy: study using Carnoy's fixation and immunohistochemistry for detection of bacteria, ALIM PHARM, 15(9), 2001, pp. 1485-1491

Authors: Kamberoglou, D Polymeros, D Sanidas, I Doulgeroglou, V Savva, S Patra, E Tzias, V
Citation: D. Kamberoglou et al., Comparison of 1-week vs. 2-or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication, ALIM PHARM, 15(9), 2001, pp. 1493-1497

Authors: Wong, WM Wong, BCY Li, TM Wong, KW Cheung, KL Fung, FMY Xia, HHX Lam, SK
Citation: Wm. Wong et al., Twenty-minute 50 mg C-13-urea breath test without test meal for the diagnosis of Helicobacter pylori infection in Chinese, ALIM PHARM, 15(9), 2001, pp. 1499-1504

Authors: Yu, J Leung, WK Ng, EKW To, KF Ebert, MPA Go, MYY Chan, WY Chan, FKL Chung, SCS Malfertheiner, P Sung, JJY
Citation: J. Yu et al., Effect of Helicobacter pylori eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasia, ALIM PHARM, 15(9), 2001, pp. 1505-1511

Authors: Press, AG Hauptmann, IA Hauptmann, L Fuchs, B Fuchs, M Ewe, K Ramadori, G
Citation: Ag. Press et al., Gastrointestinal pH profiles in patients with inflammatory bowel disease (vol 12, pg 673, 1998), ALIM PHARM, 15(9), 2001, pp. 1513-1513

Authors: Pohle, T Brzozowski, T Becker, JC van der Voort, IR Markmann, A Konturek, SJ Moniczewski, A Domschke, W Konturek, JW
Citation: T. Pohle et al., Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C (vol 15, pg 677, 2001), ALIM PHARM, 15(9), 2001, pp. 1513-1513

Authors: Souza, RF Morales, CP Spechler, SJ
Citation: Rf. Souza et al., Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett's oesophagus, ALIM PHARM, 15(8), 2001, pp. 1087-1100

Authors: Aithal, GP Mansfield, JC
Citation: Gp. Aithal et Jc. Mansfield, Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment, ALIM PHARM, 15(8), 2001, pp. 1101-1108

Authors: Duggan, JM
Citation: Jm. Duggan, Review article: transfusion in gastrointestinal haemorrhage - if, when andhow much?, ALIM PHARM, 15(8), 2001, pp. 1109-1113

Authors: Von Der Weid, PY
Citation: Py. Von Der Weid, Review article: lymphatic vessel pumping and inflammation - the role of spontaneous constrictions and underlying electrical pacemaker potentials, ALIM PHARM, 15(8), 2001, pp. 1115-1129

Authors: Fraser, JS Muller, AF Smith, DJ Newman, DJ Lamb, EJ
Citation: Js. Fraser et al., Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy, ALIM PHARM, 15(8), 2001, pp. 1131-1137

Authors: Cummings, JH Christie, S Cole, TJ
Citation: Jh. Cummings et al., A study of fructo oligosaccharides in the prevention of travellers' diarrhoea, ALIM PHARM, 15(8), 2001, pp. 1139-1145

Authors: Norton, C Kamm, MA
Citation: C. Norton et Ma. Kamm, Anal sphincter biofeedback and pelvic floor exercises for faecal incontinence in adults - a systematic review, ALIM PHARM, 15(8), 2001, pp. 1147-1154

Authors: Fackler, WK Vaezi, MF Richter, JE
Citation: Wk. Fackler et al., Ambulatory gastric pH monitoring: proper probe placement and normal values, ALIM PHARM, 15(8), 2001, pp. 1155-1162

Authors: Sanduleanu, S Jonkers, D De Bruine, A Hameeteman, W Stockbrugger, RW
Citation: S. Sanduleanu et al., Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis, ALIM PHARM, 15(8), 2001, pp. 1163-1175

Authors: Des Varannes, SB Flejou, JF Colin, R Zaim, M Meunier, A Bidaut-Mazel, C
Citation: Sb. Des Varannes et al., There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia, ALIM PHARM, 15(8), 2001, pp. 1177-1185

Authors: Adachi, K Ishihara, S Hashimoto, T Hirakawa, K Ishimura, N Niigaki, M Kaji, T Kawamura, A Sato, H Fujishiro, H Hattori, S Watanabe, M Kinoshita, Y
Citation: K. Adachi et al., Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen, ALIM PHARM, 15(8), 2001, pp. 1187-1191

Authors: Zullo, A Hassan, C Campo, SMA Lorenzetti, R Febbraro, I De Matthaeis, M Porto, D Morini, S
Citation: A. Zullo et al., A triple therapy regimen after failed Helicobacter pylori treatments, ALIM PHARM, 15(8), 2001, pp. 1193-1197

Authors: Bardhan, KD Morton, D Perry, MJ Sanders, DS Morris, P Rowland, A Thompson, M Mitchell, TR Roberts, PM
Citation: Kd. Bardhan et al., Ranitidine bismuth citrate with clarithromycin alone or with metronidazolefor the eradication of Helicobacter pylori, ALIM PHARM, 15(8), 2001, pp. 1199-1204

Authors: Weijnen, CF De Wit, NJ Numans, ME Kuipers, EJ Hoes, AW Verheij, TJM
Citation: Cf. Weijnen et al., Helicobacter pylori testing in the primary care setting: which diagnostic test should be used?, ALIM PHARM, 15(8), 2001, pp. 1205-1210

Authors: Oshima, T Pavlick, K Grisham, MB Jordan, P Manas, K Joh, T Itoh, M Alexander, JS
Citation: T. Oshima et al., Glucocorticoids and IL-10, but not 6-MP, 5-ASA or sulfasalazine block endothelial expression of MAdCAM-1: implications for inflammatory bowel diseasetherapy, ALIM PHARM, 15(8), 2001, pp. 1211-1218
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>